| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,746,600 | 3,371,400 | 3,316,200 | 3,476,900 | | Cost of Revenue | 2,464,200 |
-
| (4,743,200) | 1,898,600 | | | Gross Profit | 282,400 | 3,371,400 | 8,059,400 | 1,578,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
| 2,923,000 | 7,686,000 | 1,061,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 282,400 | 448,400 | 373,400 | 516,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,400 | 8,800 | 14,400 | 12,700 | | Earnings Before Interest And Taxes | 287,800 | 457,200 | 387,800 | 529,500 | | Interest Expense | 26,800 | 32,700 | 35,100 | 31,400 | | Income Before Tax | 261,000 | 424,500 | 352,700 | 498,100 | | Income Tax Expense | 88,700 | 142,100 | 118,200 | 167,200 | | Minority Interest |
-
| (27,400) | (27,700) | (35,000) | | | | Net Income From Continuing Ops | 178,200 | 271,000 | 213,700 | 306,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 178,200 | 271,000 | 213,700 | 306,900 | | Preferred Stock And Other Adjustments | (13,700) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $164,500 | $271,000 | $213,700 | $306,900 |
|
0.45% Nasdaq 
0.20%
Income Statement
